De Novo Psoriasis Vulgaris Diagnosed after Nivolumab Treatment for Refractory Hodgkin's Lymphoma, Completely Resolved after Autologous Hematopoietic Stem Cell Transplantation

The programmed cell death protein-1 (PD-1) inhibitor nivolumab has been recently approved as an effective and safe treatment for patients with refractory/relapsed Hodgkin's lymphomas. Dermatological adverse events, mainly skin rash, have been reported in 1–5% of patients. We describe a case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaloyannidis, Panayotis, Al Shaibani, Eshrak, Mashhour, Miral, Gamil, Mohammed, Apostolidis, Ioannis, Al Hashmi, Hani, Al Anazi, Khalid Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206568/
https://www.ncbi.nlm.nih.gov/pubmed/30410803
http://dx.doi.org/10.1155/2018/6215958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206568/
https://www.ncbi.nlm.nih.gov/pubmed/30410803
http://dx.doi.org/10.1155/2018/6215958

Ejemplares similares